Smoking as Risk-factor for Microvascular Changes in Adult Patients with Type 1 Diabetes: A Multicentre Survey;Rauchen als Risikofaktor für mikroangiopathische Veränderungen bei erwachsenen Patienten mit Typ 1 Diabetes: Eine multizentrische Feldstudie

Diabetologie und Stoffwechsel

Volumn 1, Issue 5, 2006, Pages 305-310

  Busch, P ^a   Hammes, H P ^b   Kerner, W ^c   Kern, W ^d   Dapp, A ^e   Grabert, M ^f   Holl, R W ^f  

^a SLK Kliniken Heilbronn GmbH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Klinikum Karlsburg   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

^e Kreiskrankenhaus Spaichingen   (Germany)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

Diabetes; microangiopathy; smoking

Indexed keywords

EID: 68249095327     PISSN: 18619002     EISSN: 18619010     Source Type: Journal    
DOI: 10.1055/s-2006-947259     Document Type: Article

References (17)

1. Starkman HS, Cable G, Hala V, Hecht H, Donnelly CM. Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care 2003; 26:433–436
2. Scott LJ, Warram JH, Hanna LS, Laffel LM. Ryan L, Krolewski AS. A nonlinear effect of hyperglycemia and current cigarette smoking are ma-for determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 2001; 50: 2842–2849
3. Cederholm J, Eliasson B, Nilsson PM, Weiss L, Gudbjornsdottir S. Steering Committee of the Swedish National Diabetes Register, Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res Clin Pract 2005; 67: 258–266
4. Nilsson PM, Gudbjornsdottir S, Eliasson B, Cederholm J. Steering Committee of the Swedish National Diabetes Register, Smoking is associated with increased HbAlc values and microalbuminuria in patients with diabetes- data from the National Diabetes Register in Sweden. Diabetes Metab 2004; 30: 261–268
5. Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diab Care 2002; 25: 859–864
6. Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, Binder C, Parving H-H. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004; 328: 1105–1108
7. Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complidations Study. Diabetologia 2004: 47: 1020–1028
8. Chuahirun T, Khanna A, Kimball K, Wesson DE. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes. Am J Kidney Dis 2003; 41: 13–21
9. Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB, Wesson DE. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 2004; 327: 57–67
10. Orth SR, Schroeder T, Ritz E, Ferrari P. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 2005; 20: 2414–2419
11. Warmoth L, Regalado MM, Simoni J, Harrist RB, Wesson DE. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension. Am J Med Sci 2005; 330: 111–119
12. Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, Palta M. Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. Ophthalmology 2003; 110:2118–2125
13. van Leiden HA, Dekker JM, Moll AC et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 2003; 121: 245–251
14. Stratton IM, Kohner EM, Aldington SJ et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44: 156–163
15. Hebebrand J, Heseker H, Himmelmann W, Schäfer H, Remschmidt H. Altersperzentile für den Body-Mass-Index aus Daten der Nationalen Verzehrsstudie einschlieβlich einer Übersicht zu relevanten Einfluss-faktoren. Akt Ernähr Med 1994; 19: 259–265
16. Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF. Dahl-Jorgensen K: Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes. 2002; 51: 637–2641
17. Cohen HW, Sloop GD. PDAY Study: Glucose interaction magnifies atherosclerotic risk from cholesterol. Findings from the PDAY Study. Atherosclerosis 2004; 172: 115–120